The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.